Julie E. Bauman, MD, MPH

  • Professor of Medicine
  • Chief, Division of Hematology and Oncology
  • Deputy Director, UA Cancer Center
  • Associate Director, Translational Research, UA Cancer Center

Julie E. Bauman, MD, MPH, joined the faculty of the University of Arizona College of Medicine - Tucson in September 2016 as a professor in the Department of Medicine, chief of the Division of Hematology and Oncology and director of Translational Research at the UA Cancer Center.  Previously, she was associate professor of medicine at the University of Pittsburgh Cancer Institute (UPCI), co-leader of the UPCI Head and Neck Cancer Program, director of its Head and Neck and Thyroid Cancer Sections, and co-director of the Head and Neck Cancer Center of Excellence at the University of Pittsburgh Medical Center. She has been a member of the National Cancer Institute (NCI) Head and Neck Cancer Steering Committee, and currently chairs the Immunotherapy Working Group for the NCI Recurrent/Metastatic Task Force. Before moving to Pittsburgh in 2012, Dr. Bauman was an assistant professor in the Division of Hematology/Oncology at the University of New Mexico and UNM Cancer Center in Albuquerque. She also served as chair of UNM’s head and neck cancer and lung cancer working groups. She also was its principal investigator with the Eastern Cooperative Oncology Group (ECOG)—one of the first publicly funded cooperative research groups to perform multi-center clinical trials for cancer studies. She completed her fellowship in medical oncology at the University of Washington’s Fred Hutchinson Cancer Research Center, where she was chief fellow then an assistant professor of medicine. She did her residency in internal medicine at the University of Utah and, as a clinical instructor, supervised internal medicine mid-level providers at the VA Medical Center in Salt Lake City. She earned her medical and master’s in public health degrees from Tufts University. Her undergraduate degree in psychology is from Eastern Michigan University. A native of Bethel, Alaska, Dr. Bauman grew up in Tucson and is a 1985 graduate of Salpointe Catholic High School.

Research Interests: 

Dr. Bauman's research focuses on design of biomarker-driven, early-phase clinical trials to prevent and improve survival in head and neck cancer—a disfiguring and devastating disease. Her three areas of research have focused on “green chemoprevention”—using plants such as broccoli or their simple extracts to help the body detoxify carcinogens, battling an epidemic of throat cancer caused by human papillomavirus (HPV), and the emerging field of immuno-oncology—novel treatments to activate the immune system to fight cancer. Her goal for the division is to work with faculty and staff to design and conduct rigorous clinical trials that bring cutting-edge scientific laboratory findings into the prevention and treatment of cancer.

  • MD: Tufts University School of Medicine, Boston, 1999
  • MPH: Epidemiology, Tufts University School of Medicine, Boston, 1999
  • BS: Psychology, Eastern Michigan University, Ypsilanti, Mich., 1991
Honors and Awards
  • Chief Fellow, Medical Oncology, University of Washington, Fred Hutchinson Cancer Research Center, Seattle, 2006
  • Summa cum laude, Eastern Michigan University, Ypsilanti, 1991
  • Internal Medicine, University of Utah, Salt Lake City, 2003
  • Medical Oncology, University of Washington, Fred Hutchinson Cancer Research Center, Seattle, 2006
Board Certifications
  • ABIM - Medical Oncology, 2006
  • American Board of Internal Medicine, 2003

Select Publications


Espinosa-Cotton, M., E. J. Fertig, L. P. Stabile, A. Gaither-Davis, J. E. Bauman, S. Schmitz, K. N. Gibson-Corley, Y. Cheng, I. J. Jensen, V. P. Badovinac, et al., "A preliminary analysis of interleukin-1 ligands as potential predictive biomarkers of response to cetuximab.", Biomark Res, vol. 7, pp. 14, 2019. PMCID: PMC6636109  PMID: 31346466


Bauman, J. E., E. Cohen, R. L. Ferris, D. J. Adelstein, D. M. Brizel, J. A. Ridge, B. O'Sullivan, B. A. Burtness, L. H. Butterfield, W. E. Carson, et al., "Immunotherapy of head and neck cancer: Emerging clinical trials from a National Cancer Institute Head and Neck Cancer Steering Committee Planning Meeting.", Cancer, vol. 123, issue 7, pp. 1259-1271, 2017 Apr 01. PMID: 27906454
Bauman, J. E., U. Duvvuri, W. E. Gooding, T. J. Rath, N. D. Gross, J. Song, A. Jimeno, W. G. Yarbrough, F. M. Johnson, L. Wang, et al., "Randomized, placebo-controlled window trial of EGFR, Src, or combined blockade in head and neck cancer.", JCI Insight, vol. 2, issue 6, pp. e90449, 2017 Mar 23. PMCID: PMC5358497  PMID: 28352657


Geiger, J. L., J. R. Grandis, and J. E. Bauman, "The STAT3 pathway as a therapeutic target in head and neck cancer: Barriers and innovations.", Oral Oncol, vol. 56, pp. 84-92, 2016 May. PMID: 26733183
Albergotti, W. G., K. S. Davis, S. Abberbock, J. E. Bauman, J. Ohr, D. A. Clump, D. E. Heron, U. Duvvuri, S. Kim, J. T. Johnson, et al., "Association of pretreatment body mass index and survival in human papillomavirus positive oropharyngeal squamous cell carcinoma.", Oral Oncol, vol. 60, pp. 55-60, 2016 Sep. PMCID: PMC4991628  PMID: 27531873